KIRTAMSY Trademark

Trademark Overview


On Wednesday, April 12, 2023, a trademark application was filed for KIRTAMSY with the United States Patent and Trademark Office. The USPTO has given the KIRTAMSY trademark a serial number of 79373551. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 13, 2024. This trademark is owned by Innate Pharma. The KIRTAMSY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
kirtamsy

General Information


Serial Number79373551
Word MarkKIRTAMSY
Filing DateWednesday, April 12, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnate Pharma
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameInnate Pharma
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, July 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 11, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Wednesday, January 10, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 25, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 14, 2024REFUSAL PROCESSED BY IB
Tuesday, July 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 9, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024REFUSAL PROCESSED BY MPU
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED